Flamm J
Wien Med Wochenschr. 1982 Feb 15;132(3):49-53.
In 51 patients with malignant kidney tumours, who were checked up postoperatively over a time of at least five years, the tumour nephrectomy was carried out lumbodorsally in 19 cases (37.2%) and transperitoneally in 32 cases (62.7%). There was a total survival rate of 49% after five years. When using the lumbodorsal technique of tumour nephrectomy the five year survival rate came to the total of 52.6%, in T2-tumours to 62% and in T3-tumours to 0%. By taking the transperitoneal way the five year survival rate amounted to the total of 53%, in T2-tumours to 70% and in T-3 tumours to 36%. Large tumor size and signs of tumour invasion can definitely be considered as prognostically unfavourable factors. In such cases the transperitoneal technique of tumour nephrectomy yields better chances of survival. When taking into consideration the heavy chances of understaging a tumour diagnostically and the possibility of local tumour invasion even in small tumours, it is of great importance the transperitoneal technique as the method with the best possible results.
在51例恶性肾肿瘤患者中,术后至少随访了5年,其中19例(37.2%)采用腰背部入路行肿瘤肾切除术,32例(62.7%)采用经腹入路。5年后总生存率为49%。采用腰背部肿瘤肾切除技术时,5年生存率总计为52.6%,T2期肿瘤为62%,T3期肿瘤为0%。采用经腹入路时,5年生存率总计为53%,T2期肿瘤为70%,T3期肿瘤为36%。肿瘤体积大及肿瘤侵犯征象肯定可被视为预后不良因素。在这种情况下,经腹肿瘤肾切除技术能带来更好的生存机会。考虑到肿瘤诊断分期不足的可能性很大,以及即使小肿瘤也可能发生局部肿瘤侵犯,经腹技术作为能取得最佳结果的方法非常重要。